NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/05/2023
Back to search
Official data from USPTO
TRIPLE THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRIPLE THERAPY
ST13
US500000076297522Class
5
Filing
76297522
Registration
2725469
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
10/05/2023
Trademark type
Word
Nice classes
5
Filing date
08/10/2001
Registration date
06/10/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2023
Last transaction
10/05/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/03/2002
First use in commerce
12/03/2002
Drawing code
1
Owner type
16
Owner location
WESTLAKE VILLAGE, CA
Examiner
JOHNSON, AISHA
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
AKESO HEALTH SCIENCES, LLC
AKESO, LLC
AKESO, LLC
N. A. (pessoa física)
Representatives
L. S. VAN LANDINGHAM, III
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
dietary supplements consisting of vitaminsmineralsherbal extracts and other nutrients
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/05/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/05/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/05/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/05/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
04/04/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2016
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/20/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/20/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/20/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/20/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
03/01/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/23/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/16/2009
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
12/14/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/14/2009
ES8R
TEAS SECTION 8 RECEIVED
12/10/2009
CFIT
CASE FILE IN TICRS
05/01/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/16/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/14/2003
PAPER RECEIVED
02/20/2003
IUAF
USE AMENDMENT FILED
01/24/2003
PAPER RECEIVED
01/24/2003
EX1G
SOU EXTENSION 1 GRANTED
08/05/2002
EXT1
SOU EXTENSION 1 FILED
07/29/2002
PAPER RECEIVED
07/29/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/05/2002
PUBO
PUBLISHED FOR OPPOSITION
11/13/2001
NPUB
NOTICE OF PUBLICATION
10/24/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2001
DOCK
ASSIGNED TO EXAMINER
09/18/2001
Continuous trademark protection
Get notified about every new filing that threatens TRIPLE THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.